Paper28086993
Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
Hanaoka H and 13 others. Arthritis Res Ther, 2017. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV. Papers, record 28086993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28086993
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunosuppressive Agents | Major topic |
| Lupus Nephritis | Major topic |
| Adult | |
| Female | |
| Humans | |
| Induction Chemotherapy | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Remission Induction | |
| Retrospective Studies | |
| Treatment Outcome |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9324032 | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. | Arthritis Rheum | 1997 | https://conductscience.org/library/papers/9324032 | PubMed |
| 2 | 12966597 | Accrual of organ damage over time in patients with systemic lupus erythematosus. | J Rheumatol | 2003 | https://conductscience.org/library/papers/12966597 | PubMed |
| 3 | 25757867 | Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/25757867 | PubMed |
| 4 | 15334470 | Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. | Arthritis Rheum | 2004 | https://conductscience.org/library/papers/15334470 | PubMed |
| 5 | 17265497 | Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. | Arthritis Rheum | 2007 | https://conductscience.org/library/papers/17265497 | PubMed |
| 6 | 835580 | Lupus nephritis. Clinical course as related to morphologic forms and their transitions. | Am J Med | 1977 | https://conductscience.org/library/papers/835580 | PubMed |
| 7 | 8607884 | The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. | Arthritis Rheum | 1996 | https://conductscience.org/library/papers/8607884 | PubMed |
| 8 | 22129255 | Systemic lupus erythematosus. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22129255 | PubMed |
| 9 | 19369404 | Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19369404 | PubMed |
| 10 | 1599520 | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Arthritis Rheum | 1992 | https://conductscience.org/library/papers/1599520 | PubMed |
| 11 | 1251849 | The bimodal mortality pattern of systemic lupus erythematosus. | Am J Med | 1976 | https://conductscience.org/library/papers/1251849 | PubMed |
| 12 | 22851469 | Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. | Ann Rheum Dis | 2012 | https://conductscience.org/library/papers/22851469 | PubMed |
| 13 | 309095 | Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. | N Engl J Med | 1978 | https://conductscience.org/library/papers/309095 | PubMed |
| 14 | 25861455 | Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort. | Lupus Sci Med | 2015 | https://conductscience.org/library/papers/25861455 | PubMed |
| 15 | 10743809 | Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. | J Rheumatol | 2000 | https://conductscience.org/library/papers/10743809 | PubMed |
| 16 | 11237132 | Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. | Lupus | 2001 | https://conductscience.org/library/papers/11237132 | PubMed |
| 17 | 19208608 | Prednisone, lupus activity, and permanent organ damage. | J Rheumatol | 2009 | https://conductscience.org/library/papers/19208608 | PubMed |
| 18 | 24739325 | Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. | Ann Rheum Dis | 2014 | https://conductscience.org/library/papers/24739325 | PubMed |
| 19 | 18003764 | Value of a complete or partial remission in severe lupus nephritis. | Clin J Am Soc Nephrol | 2008 | https://conductscience.org/library/papers/18003764 | PubMed |
| 20 | 20131293 | Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. | Arthritis Rheum | 2010 | https://conductscience.org/library/papers/20131293 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41898159 | Clinical and Biochemical Factors Associated with Delayed Renal Response in Proliferative Lupus Nephritis: A 20-Year Single-Center Multiethnic Cohort Study. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898159 | PubMed |
| 38940925 | Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis. | Eur J Pediatr | 2024 | https://conductscience.org/library/papers/38940925 | PubMed |
| 37452914 | Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention. | Curr Rheumatol Rep | 2023 | https://conductscience.org/library/papers/37452914 | PubMed |
| 36255555 | Management and outcomes in children with lupus nephritis in the developing countries. | Pediatr Nephrol | 2023 | https://conductscience.org/library/papers/36255555 | PubMed |
| 36078950 | Predictors of Early Response, Flares, and Long-Term Adverse Renal Outcomes in Proliferative Lupus Nephritis: A 100-Month Median Follow-Up of an Inception Cohort. | J Clin Med | 2022 | https://conductscience.org/library/papers/36078950 | PubMed |
| 35854166 | Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients. | Clin Rheumatol | 2022 | https://conductscience.org/library/papers/35854166 | PubMed |
| 35498799 | What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012? | Front Pediatr | 2022 | https://conductscience.org/library/papers/35498799 | PubMed |
| 34636151 | Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis. | Int J Rheum Dis | 2021 | https://conductscience.org/library/papers/34636151 | PubMed |
| 32500443 | An Update on the Diagnosis and Management of Lupus Nephritis. | Curr Rheumatol Rep | 2020 | https://conductscience.org/library/papers/32500443 | PubMed |
| 31296139 | Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan. | Lupus | 2019 | https://conductscience.org/library/papers/31296139 | PubMed |
| 30159624 | Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus. | Pediatr Nephrol | 2019 | https://conductscience.org/library/papers/30159624 | PubMed |
| 29720229 | Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV. | Arthritis Res Ther | 2018 | https://conductscience.org/library/papers/29720229 | PubMed |
| 28982696 | Calcineurin Inhibitors in the Treatment of Lupus Nephritis: A Hare Versus Turtle Story? | J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28982696 | PubMed |
| 28384208 | Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study. | PLoS One | 2017 | https://conductscience.org/library/papers/28384208 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C1QA | 712 | PubTator's text mining | https://conductscience.org/library/genes/712 | NCBI Gene |
| CD79A | 973 | PubTator's text mining | https://conductscience.org/library/genes/973 | NCBI Gene |
| FGB | 2244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28086993
GET https://conductscience.org/api/papers/v1/28086993/references?page=2